Skip to content

Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients

A Multicenter Randomized Controlled Trial of Routine Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02772731
Acronym
SHAVE2
Enrollment
400
Registered
2016-05-13
Start date
2016-07-31
Completion date
2024-11-30
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

mastectomy

Brief summary

Breast cancer is the most common malignancy affecting women in the US. Surgical management is the mainstay of therapy, and in general consists of resection of the primary tumor with either a partial mastectomy (aka lumpectomy) or a total mastectomy. The investigators hypothesize that routine shave margins during partial mastectomy will significantly reduce positive margin rate. A positive margin means that cancerous cells were detected at the edge of the excised area. This generally mandates a return to the operating room for re-excision.

Detailed description

Some authors have investigated, in a retrospective fashion, the use of routine shave margins, where surgeons routinely take additional margins at the time of the initial partial mastectomy as a means of obtaining negative margins. While these retrospective studies have found that positive margin rates declined using this technique, opponents to this technique wonder if this truly results in a higher negative margin rate without compromising cosmesis or increasing tissue volume removed. As these studies were retrospective, it was possible that the initial resection was smaller than what those who do not routinely take shave margins would resect. No one had evaluated the impact of further resection on operative time, nor in a blinded fashion, evaluated cosmesis. Further, there had yet to be a prospective study to evaluate the impact of this on local recurrence rates. Hence, the investigators performed a prospective randomized controlled trial of this technique at Yale. The data from this study, published in the New England Journal of Medicine, found that the technique cut positive margin and re-excision rates in half. Some wondered, however, about the external generalizability of these findings, particularly in non-academic settings. Hence, a multicenter trial to validate these findings is warranted.

Interventions

PROCEDUREPartial mastectomy plus additional Shave Margin

For the shave group, additional superior, inferior, medial and lateral margins will be removed, oriented, and sent for pathologic evaluation at the local site. Resection of additional anterior and posterior margins will be left to surgeon discretion, as this will depend on if skin or fascia was taken. All surgeons participating in the study will be educated on the expectation of what is considered a shave margin. A shave margin is defined as an additional segment of breast tissue taken from each of the superior, inferior, medial, and lateral aspects of the cavity, such that the entire circumference of the cavity is re-excised following this procedure. Orientation of each shaved margin will be done to mark the true margin.

Surgeons will be instructed to close after partial mastectomy with no further excision.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Breast cancer, stage 0-3, deemed a surgically appropriate candidate for partial mastectomy with planned procedure for the same 2. Women ≥ 18 years of age 3. Ability to understand and the willingness to sign a written informed consent document. Exlusion Criteria 1. Total mastectomy 2. Known metastatic disease 3. Bilateral synchronous breast cancer 4. Multicentric cancers requiring double lumpectomy 5. Previous history of breast cancer (even in the other breast) 6. Patients receiving Intraoperative radiation therapy (IORT) 7. Patients who had excisional biopsy for diagnosis of their cancer (I.e., instead of a core biopsy)

Design outcomes

Primary

MeasureTime frameDescription
Positive margin rateimmediately after surgeryThe effect is positive margin rate post-surgery as measured by local pathological reports. Positive margins were defined as tumor touching the edge of the specimen that was removed in patients with invasive cancer and tumor that was within 2 mm of the edge of the specimen removed in those with ductal carcinoma in situ.

Secondary

MeasureTime frameDescription
local recurrence ratesup to 5 yearsPatients will be assessed for local recurrence based on physical examination, mammography, and follow up phone calls. This is a composite score with only one outcome and only one unit (respondents). A positive results from any of these methods indicates recurrence.
patient perceived cosmesis1 year post-opSubjects will be asked their perception of physical appearance: poor, fair, good, or excellent.
volume of tissue resectedimmediately after tissue resectionbased on the sum of the volumes of tissue excised as found in the gross description of the specimens on the pathology report.
Quality of Life assessment1 year post-op about the last seven daysQuality of Life Questionnaire measures quality of life over the past 7 days and includes 75 questions that are answered on a Likert scale. Questions assess physical, social, emotional and functional well-being in addition to cosmetic and physical appearance and questions regarding the surgery. Higher scores indicate a higher quality of life.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026